[1] DAVIES D M,MAHER J.Adoptive T-cell immunotherapy of cancer using chimeric antigen receptor-grafted T cells[J].Arch Immunol Ther Exp (Warsz),2010,58(3):165-178.
[2] GRUPP S A,KALOS M,BARRETT D,et al.Chimeric antigen receptor-modified T cells for acute lymphoid leukemia[J].N Engl J Med,2013,368(16):1509-1518.
[3] BARRETT D M,TEACHEY D T,Grupp S A.Toxicity management for patients receiving novel T-cell engaging therapies[J].Curr Opin Pediatr,2014,26(1):43-49.
[4] LEE DW,GARDNER R,PORTER DL,et al.Current concepts in the diagnosis and management of cytokine release syndrome[J].Blood,2014,124(2):188-195.
[5] HAY K A.Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-)T cell therapy[J].Br J Haematol,2018,183(3):364-374.
[6] NEELAPU S S,TUMMALA S,KEBRIAEI P,et al.Chimeric antigen receptor T-cell therapy- assessment and management of toxicities[J].Nat Rev Clin Oncol,2018,15(1):47-62.
[7] GOFSHTEYN J S,SHAW P A,TEACHEY D T,et al.Neurotoxicity after CTL019 in a pediatric and young adult cohort[J].Ann Neurol,2018,84(4):537-546.
[8] LI S,YANG Z,SHEN J,et al.Adoptive therapy with CAR redirected T cells for hematological malignancies[J].Sci China Life Sci,2016,59(4):370-378.
[9] HENG G,JIA J K,LI S Q,et al.Sustained therapeutic efficacy of humanized anti-CD19 chimeric antigen receptor T cells in relapsed/refractory acute lymphoblastic leukemia[J].Clin Cancer Res,2020,26(7):1606-1615.
[10] XIAO X,HE X Y,LI Q,et al.Plasma exchange can be an alternative therapeutic modality for severe cytokine release syndrome after chimeric antigen receptor-T cell infusion:a case report[J].Clin Cancer Res,2019,25(1):29-34.
[11] 王庭槐.生理学[M].北京:人民卫生出版社.2018:69.
[12] 栾松华,王红新,刘代红,等.输血器输注造血干细胞对细胞植入“零”影响的论证研究[J].中国输血杂志,2019,32(3):292-294.
[13] 美国静脉输液护理学会.输液治疗实践标准[J].中华护理杂志,2016,51(10s):1-142.
[14] 李丽娜,万滢.嵌合抗原受体修饰T细胞免疫疗法治疗B细胞恶性肿瘤患者的护理[J].中华护理杂志,2017,52(3):297-299.
[15] LEE D W,GARDNER R,PORTER D L,et al.Current concepts in the diagnosis and management of cytokine release syndrome[J].Blood,2014,124(2):188-195.
[16] CHEN A P,SETSER A,ANADKAT M J,et al.Grading dermatologic adverse events of cancer treatments:the Common Terminology Criteria for Adverse Events Version 4.0[J].J Am Acad Dermatol,2012,67(5):1025-1039.
[17] 张佳思,阮潜瑛,符刚,等.急性白血病患者CAR-T治疗的护理[J].护理学杂志,2018,33(1):28-30.
[18] 王叶飞,沈璐梦,蒋红娜,等.改良后盐水冰袋在新布尼亚病毒感染患者高热护理中的疗效观察[J].护士进修杂志,2017,32(3):285-286.
[19] 徐丽,唐叶丹,陈琳,等.造血干细胞移植联合CAR-T治疗复发难治B细胞肿瘤患者并发症的护理[J].护理学杂志,2018,33(17):32-34.
[20] 张佳媛,周郁秋,张全志,等.正念减压疗法对乳腺癌患者知觉压力及焦虑抑郁水平的影响[J].中华护理杂志,2015,50(2):189-193.
[21] CHEADLE E J,GORNALL H,BALDAN V,et al.CAR T cells:driving the road from the laboratory to the clinic[J].Immunol Rev,2014,257(1):91-106.
[22] BOUHASSIRA D C,THOMPSON J J,DAVILA M L.Using gene therapy to manipulate the immune system in the fight against B-cell leukemias[J].Expert Opin Biol Ther,2015,15(3):403-416. |
